Vaccine R&D: Past performance is no guide to the future
- 1 April 2014
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 32 (19), 2139-2142
- https://doi.org/10.1016/j.vaccine.2014.02.047
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Delivering the promise of the Decade of Vaccines: Opportunities and challenges in the development of high quality new vaccinesVaccine, 2013
- Risk in Vaccine Research and Development QuantifiedPLOS ONE, 2013
- Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipelineVaccine, 2011
- Accelerating vaccine development and deployment: report of a Royal Society satellite meetingPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2011
- Malaria elimination: how far can we go without a vaccine?Clinical Medicine, 2011
- Vaccines for the treatment of non-small cell lung cancer: Investigational approaches and clinical experienceLung Cancer, 2011
- Trends in Risks Associated With New Drug Development: Success Rates for Investigational DrugsCancer Cell, 2010
- Lessons from 60 years of pharmaceutical innovationNature Reviews Drug Discovery, 2009
- Demand Forecasting for Preventive??AIDS VaccinesPharmacoEconomics, 2008
- Vaccine R&D success rates and development timesNature Biotechnology, 1996